Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/16/21 | 8-K | Current report filing |
|
   |
4 |
| 08/16/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
23 |
| 08/03/21 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
58 | |
| 07/28/21 | UPLOAD | SEC-generated letter |
|
1 | |
| 07/22/21 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
19 | |
| 07/15/21 | 8-K | Current report filing |
|
2 | |
| 06/14/21 | 8-K | Current report filing |
|
2 | |
| 06/14/21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 06/09/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/09/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
